United States · Biotechnology startup

Omega Therapeutics

Omega Therapeutics offers a proprietary epigenomic programming platform.

Funding reportedLast round: Post ipo equity

BiotechnologyCambridge, United States

What company datasets say Omega Therapeutics raised

Funding, as reported

Reported in all$279Min dollars
Rounds4
Last roundPost ipo equity
Last round dateFeb 2023
Investors listed11

Biotechnology in United States

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Omega Therapeutics in front of investors. Or tell us what we have wrong.